NCT06504576View on ClinicalTrials.gov

Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

May 1, 2027

Study Completion Date

May 1, 2027

Conditions
ICH - Intracerebral Hemorrhage
Interventions
DRUG

Cilostazol 50 MG Oral Tablet

Two consecutive weeks of Cilostazol (50mg BID) two days after admission

PROCEDURE

Conventional internal medicine treatment

Receives only conventional internal medicine treatment

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER